Cargando…

B-Raf mutation and papillary thyroid carcinoma patients

Thyroid carcinoma is the most prevalent endocrine neoplasm globally. In the majority of thyroid carcinoma cases, a positive prognosis is predicted following administration of the appropriate treatment. A wide range of genetic alterations present in thyroid carcinoma exert their oncogenic actions par...

Descripción completa

Detalles Bibliográficos
Autores principales:	JIANG, LIXIN, CHU, HAIDI, ZHENG, HAITAO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812206/ https://www.ncbi.nlm.nih.gov/pubmed/27073540 http://dx.doi.org/10.3892/ol.2016.4298

Ejemplares similares

Pin1 is related with clinical stage of papillary thyroid carcinoma
por: Jiang, Lixin, et al.
Publicado: (2016)

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor
por: Zheng, Haitao, et al.
Publicado: (2016)

A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer
por: Ma, Hongzhi, et al.
Publicado: (2020)

Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients
por: Lu, Yi, et al.
Publicado: (2020)

Lack of Association of B-type Raf Kinase V600E Mutation with High-risk Tumor Features and Adverse Outcome in Conventional and Follicular Variants of Papillary Thyroid Carcinoma
por: Nair, C. Gopalakrishnan, et al.
Publicado: (2017)

Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients
por: Liu, Riming, et al.
Publicado: (2017)

Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling
por: Poyil, Pratheesh Kumar, et al.
Publicado: (2023)

TSH Signaling Overcomes B-RafV600E–Induced Senescence in Papillary Thyroid Carcinogenesis through Regulation of DUSP6()()
por: Kim, Young Hwa, et al.
Publicado: (2014)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Microarray profiling of circular RNAs in human papillary thyroid carcinoma
por: Peng, Nianchun, et al.
Publicado: (2017)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

Ultrasonographic imaging of papillary thyroid carcinoma variants
por: Shin, Jung Hee
Publicado: (2017)

Mutation of Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes
por: Zhang, Lizhuo, et al.
Publicado: (2021)

Active surveillance in low risk papillary thyroid carcinoma
por: Pitoia, Fabian, et al.
Publicado: (2020)

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype
por: Aprile, Marianna, et al.
Publicado: (2023)

Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis
por: Zheng, Guibin, et al.
Publicado: (2017)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

Simultaneous Pheochromocytoma, Paraganglioma, and Papillary Thyroid Carcinoma without Known Mutation
por: Rasquin, Lorena, et al.
Publicado: (2018)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates
por: Al-Salam, Suhail, et al.
Publicado: (2020)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(’)s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma
por: Zeng, Chao, et al.
Publicado: (2022)

Thyroid papillary carcinoma associated to Hashimoto's thyroiditis
por: Campos, Luiz Alexandre Albuquerque Freixo, et al.
Publicado: (2015)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Detection of human parvovirus B19 in papillary thyroid carcinoma
por: Wang, J H, et al.
Publicado: (2008)

Association of the characteristics of B- and T-cell repertoires with papillary thyroid carcinoma
por: Sun, Guoping, et al.
Publicado: (2018)

Synchronous Independent Papillary Thyroid Carcinomas in Struma Ovarii and the Thyroid Gland With Different RAS Mutations
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2018)

B-Raf and the inhibitors: from bench to bedside
por: Huang, Tiangui, et al.
Publicado: (2013)

Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2010)

The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
por: Dillon, Laura W., et al.
Publicado: (2012)

High BRAF(V600E) mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules
por: Li, Xing-Jia, et al.
Publicado: (2019)

Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto’s Thyroiditis
por: Zhang, Qin, et al.
Publicado: (2017)

Hypervascularity is more frequent in medullary thyroid carcinoma: Compared with papillary thyroid carcinoma
por: Lai, Xingjian, et al.
Publicado: (2016)

Incidental Papillary Microcarcinoma and Papillary Thyroid Carcinoma in Multinodular Goiter
por: Arican, Cigdem D., et al.
Publicado: (2023)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g27d2mb4vpaitalm10i3tq1757